--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


Fitbit & Google: What Citron Got Right, and Wrong ?1



Citron Research recently issued a report declaring a $15 price target for Fitbit (FIT).  This article will provide alternate perspective on that report, going into detail on what it got right, and what it omitted, by contrasting with the hands-on Versa research done by CrowdWisers.

I'd like to begin by saying that I have a great deal of respect for Andrew Left and Citron Research.  Short sellers often get a bad rap for essentially giving the market a dose of reality.  Although many short attacks are misleading and inaccurate, Citron's are generally well-sourced and based in fact.  That represents a refreshing dose of honesty as compared to the constant hype that is bandied by long sell-side analysts and pundits.  Like any good short-seller, Andrew Left is a student of market dynamics, and I commend him for taking advantage of the opportunity in this situation.  Now let's look at how long that opportunity is likely to last.

CrowdWisers Versa Evaluation Parameters

The Versa purchased by CrowdWisers was given to an active female professional for evaluation on May 4th.  It's taken us quite a while get an assessment of the Versa out, and the reasons why are significant.  Quick Replies and female health tracking features were announced as available just three days later.  Despite this, the new functionality was not available on our model until May 14th.  This is because Fitbit actually rolled the features out only very gradually in order to test them.  Processes like this have become common, even with end-user devices, but as a programmer, I find them to be sad commentary on the state of both software development and consumer relations these days.

While we waited for the features we most wanted to test, the user quickly came up with the following list of Pros and Cons about the Versa's basic functionality:

Pros:

Cons:

Dancing with the Devil

This last point raises a point that I think is crucially misunderstood by Citron and the overall market about the recent collaboration with Google.  Alphabet (GOOG) has literally left any trace of its original "Don't be evil" motto behind.  Most consumers have become inured to the privacy concerns that should go along with their personal data being stored on anywhere other than on their own private devices.  So the marketing impact of this new agreement should be minimal or even slightly positive.  What I'm concerned with is the competitive trade off.  Fitbit gets a more reliable and capable cloud than the one that failed it just before the agreement was announced.  CrowdWisers published research correlating that incident to problems with Amazon's (AMZN) AWS services.

What does Google get?  Besides poaching a client, it gets information it can use to further its own health care initiatives, which is all well and good on the big data side where Fitbit was never realistically going to out-compete the behemoths anyway.  However, on the data collection edges, where Fitbit makes its (meager, as of late) living, I posit that Google gets exactly the usage data it needs to fine tune its own wearable devices and the software that runs them.  My position is supported by Fitbit's
Terms of Service
By making Your Content available on or through the Fitbit Service you hereby grant to Fitbit a non-exclusive, transferable, sublicensable, worldwide, royalty-free license to use, copy, modify, publicly display, publicly perform, reproduce, translate, create derivative works from, and distribute Your Content, in whole or in part, including your name and likeness, in any media.
and its Privacy Policy
We transfer information to our corporate affiliates, service providers, and other partners who process it for usThese partners provide us with services globally, including for customer support, information technology, payments, sales, marketing, data analysis, research, and surveys. These partners provide us with services globally, including for customer support, information technology, payments, sales, marketing, data analysis, research, and surveys.
I'm not claiming that Google is going to be spying on whether or not you slacked off last Thursday, though anyone who doubts the possibility of even that level of invasive analytics should revisit Facebook's history with Cambridge Analytica.  The real danger here is that Google is able to make aggregate observations for fine tuning Wear OS, and showing what anyone who's really analyzed this space already knows: that the current generation of products are great motivational tools, but poor diagnostic devices.

As I wrote in my private coverage of Fitbit's 4Q17 report, Fitbit and Garmin have enjoyed temporary shelter from from Android competition because of stagnant hardware:
The one thing Fitbit does still have going for it in the short term is that wearable market is still the wild west.  Per this article:
Android Wear is not a perfect smartwatch operating system, but the primary problem with Android Wear watches is the hardware, like size, design (which is closely related to size), speed, and battery life. All of these are primarily influenced by the SoC, and there hasn't been a new option for OEMs since 2016. There are only so many ways you can wrap a screen, battery, and body around an SoC, so Android smartwatch hardware has totally stagnated.
That represents a barrier to entry, at least until Google starts taking a deeper interest.
Well, those days are about to be over with the introduction of a new SoC (system on chip) from Qualcomm (QCOM) this fall, which will probably debut with a Google branded wearable.  It will be followed by host of new holiday season competitors with the vastly improved battery life that comes with modern foundry production.  Expect that to be accompanied by plenty of technically independent media reports pointing out the flaws in current health data collection.  However, I expect the deadliest point of comparison will be something I've harped on for a long time...

Messaging

If you've been following my thoughts on wearables, you know that I think messaging is the other key feature (along with health tracking) for the market.  Though some have wanted more, we found Quick Replies easy to use and reliable, assuming you become aware of the notification at all.  However, Fitbit has not included any ability to dictate a response, likely because its software is not up to the task.  Alphabet's clearly is, and I expect this functionality to really come to the fore in the next iteration of devices based on the hardware and software mentioned above.  When it does, I think Fitbit is going to have major problems competing.  Our test user supports this, saying
I like receiving texts, when it happens to be connected to my phone.  Quick-replies are a nice to have, but honestly, I have not had too many scenarios when I use them because the conversation needs more than a canned response a lot of the time.
I already dictate messages most of the time on my phones.  I just don't see any way that Fitbit (or Garmin, for that matter) can match Google when it comes to voice recognition.  Arguably, the Flyer headphones, which have a microphone, can simply interface to Android to make use of that functionality, as could a future watch with a microphone.  Nonetheless, I think Fitbit's integration will lag that of native Android and iOS devices.

Financial Analysis

Fitbit hasn't been profitable since 2016, and my Ionic review correctly predicted that the trend would worsen as its smart watches were forced to compete on price rather than features.  The Versa should temporarily mitigate that trend, but management's goal for this year is merely to get to break-even cash flow.  With deadly new competition on the way, that puts the floor for FIT shares at cash on the balance sheet.  My analysis of that as of the last report went like this:

The company had $658M of cash and equivalents on the balance sheet, no debt, and an $80M tax refund on the way.  However, management admits that they don't have all the pieces for real healthcare integration in place, and they expect to get them through M&A.  It also labels the new work with Google as being in the exploratory phase, and notes that it will free up engineering capacity.
So, best case hard value, with the tax refund and not subtracting for health care integration expenditures is $3.51 per share.  Note that this includes Fitbit's own projections on new revenue streams like Coach, which management said grew 30% YoY.  That statement seems as squishy as those associated with the software roll-outs, as Coach was just introduced in August.  No matter what the time frame is, the growth rate doesn't impress me for a new service.

Realistically, though, I don't think FIT will get below $4 without a general market crash, just based on years of trading experience.  However, once actual sales start to be reported in a newly competitive environment, I can easily see FIT back below $5.  That represents over 30% nominal gain on a short position and more on an annualized basis. 

Buyout?

Another point raised by Citron is the possibility of buyout, which generally serves as a emotional refuge for desperate longs everywhere.  It's impossible to refute definitively, since it is hypothetical, and offers a sort of deus ex-machina ending for what is otherwise a bad situation.  Citron raises this point repeatedly, and I agree!  Fitbit is likely to be bought, eventually, but that's not a reason to own it, as shown by the history of InvenSense.  In fact, the share appreciation caused by Citron makes this possibility far less likely in the near term.  Any would-be buyer which had done its due diligence would be looking for a better price while waiting for competitive factors to take their toll. 

Summary

Over the current and coming quarters, I suspect Versa sales will improve Fitbit's unit numbers substantially, but its margins less.  Citron only needed to take a quick look at the factors I've detailed in conjunction with over 14% shorted-float in order to identify an opportunity to make a quick buck.  I commend Mr. Left for a successful market hack, but the resultant movement in FIT shares now positions the stock better as market hedge, or outright short, as we move towards 2019.  Should Mr. Left wish to take issue with the long-term analysis provided here, I invite Citron to negotiate a public bet with CrowdWisers, based on Fitbit fundamentals, with Seeking Alpha staff as the arbiters. 

Good investing is generally a marathon, not a sprint.  New wearables based on the new Qualcomm SoC are likely to allow the Android ecosystem to shine in ways that will be difficult for others to match.  Garmin may be somewhat insulated by its high-end market positioning but the going is likely to be especially tough on the value end of the market, where Fitbit has been forced.  The latest data from Canalys also shows the company facing declining interest in its legacy trackers, as new, smaller competition starts moving that functionality from the wrist to the finger.  Consequently, while Fitbit is seemingly start to hit its stride with the Versa, don't be surprised to see the company sucking wind again as we stride into 2019.